PDS Biotechnology Corpora... (PDSB)
NASDAQ: PDSB
· Real-Time Price · USD
1.24
-0.05 (-3.88%)
At close: May 13, 2025, 3:59 PM
1.33
7.26%
After-hours: May 13, 2025, 07:47 PM EDT
-3.88% (1D)
| Bid | 1.23 |
| Market Cap | 56.63M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -37.61M |
| EPS (ttm) | -1.03 |
| PE Ratio (ttm) | -1.2 |
| Forward PE | -1.2 |
| Analyst | Buy |
| Ask | 1.33 |
| Volume | 384,157 |
| Avg. Volume (20D) | 632,479 |
| Open | 1.31 |
| Previous Close | 1.29 |
| Day's Range | 1.21 - 1.31 |
| 52-Week Range | 0.85 - 4.42 |
| Beta | 1.39 |
About PDSB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PDSB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PDSB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-8.21%
PDS Biotechnology shares are trading higher after ...
Unlock content with
Pro Subscription
2 months ago
-11.69%
PDS Biotechnology shares are trading lower after the company announced a $22 million registered direct offering. The stock initially traded higher, but it has since reversed.
1 month ago · seekingalpha.com
PDS Biotechnology Corporation (PDSB) Q4 2024 Earnings Call TranscriptPDS Biotechnology Corporation (NASDAQ:PDSB ) Q4 2024 Earnings Conference Call March 27, 2025 8:00 AM ET Company Participants Tom Johnson - LifeSci Advisors Frank Bedu-Addo - CEO Kirk Shepard - Chief M...
2 months ago · proactiveinvestors.co.uk
EMV Capital portfolio company PDS Biotechnology raises $11mlnEMV Capital plc (AIM: EMVC) portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) has raised $11 million, through an equity funding. PDS, which is focussed on immunotherapies, sold around 7.3...